The Promise of Targeted Therapies for NF2
Targeted therapies are changing the landscape for NF2. Unlike traditional treatments, these drugs target specific molecular pathways involved in tumor growth. For patients with NF2, they offer new hope. The market is responding with investment and innovation. Bevacizumab, which targets VEGF, is the most established targeted therapy for NF2. It can reduce tumor size and improve hearing in some...
0 Commentaires 0 Parts 7 Vue 0 Aperçu
Moundo https://moundo.social